Park Ha Biological Technology is trading 15.7% up in pre-market at $2.72, with the catalyst unclear. - On October 5, 2026, shares are at $2.72 versus the October 2 close of $2.35, following a sharp rebound after several declining sessions. - The company’s investor-relations press-release page lists its latest release on July 6, 2026; no clear company-specific announcement explaining the move surfaced. - Major U.S. indices are slightly lower pre-market, so broad-market strength does not explain the rise.